Mostrar el registro sencillo del ítem
dc.contributor.author | Ugarte Gil, Cesar Augusto | |
dc.contributor.author | Pearson, F. | |
dc.contributor.author | Moore, David Alexander James | |
dc.contributor.author | Critchley, J. | |
dc.contributor.author | van Crevel, R. | |
dc.date.accessioned | 2019-08-08T15:23:45Z | |
dc.date.available | 2019-08-08T15:23:45Z | |
dc.date.issued | 2019 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/7133 | |
dc.description.abstract | We thank Drs Yates and Barr for their valuable comments. In our article [1], we were not attempting to assess the extent to which dysglycemia is causally associated with tuberculosis (TB). A number of prospective studies exist, among a body of evidence, supporting probabilistic causation between diabetes mellitus (DM) and TB [2, 3]. Rather, the aim of our study was to identify age-adjusted prevalence and clinical characteristics of DM and intermediate hyperglycemia among those with newly diagnosed TB across 4 TB-endemic settings. In our South African population, the prevalence of DM (10.9% [95% confidence interval, 7%–14.9%]) was the... | en_US |
dc.language.iso | eng | |
dc.publisher | Oxford University Press | |
dc.relation.ispartofseries | Clinical Infectious Diseases | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | tuberculosis | en_US |
dc.subject | dysglycemia | en_US |
dc.subject | diabetes mellitus | en_US |
dc.subject | associated factors | en_US |
dc.title | Reply to Yates and Barr | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1093/cid/ciz434 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
dc.relation.issn | 1537-6591 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |